-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: What are the unique advantages of a humanized model of the immune system?
Author:
InnoModels
Release time:
2024-03-22
With the continuous progress of science and technology, mankind's understanding of living organisms has gradually deepened. In the medical field, in order to better simulate the human environment for disease research and drug screening, scientists have developed humanized models. The humanized model of immune system of InnoModels Biotechnology, with its unique advantages, has brought a new dawn for medical research.
I. High Stability: Stable Reconstruction of Immune System
Traditional immune system models often face stability problems, and the reproducibility of experimental results is not strong, resulting in scientific research being hindered. However, the humanized model of the immune system of InnoModels Biotechnology has successfully solved this problem by virtue of its high stability. After improvement, the success rate of experimental modeling has increased from the original 50% to an amazing 87%. This means that researchers can have more confidence in the reliability of the experimental results and conduct in-depth investigations on the basis of using the model of InnoModels.
In addition to the increase in modeling success rate, the stability of the model from InnoModels Biotechnology is also reflected in the significant reduction of the within-group coefficient of variation. The intra-group coefficient of variation is an important indicator of the consistency of experimental results, and the lower its value, the less fluctuation of experimental results and the more stable they are. After optimization, the within-group coefficient of variation of the model has been drastically reduced from the original 120% to 20%, providing more reliable experimental data for researchers.

Multi-cell reconstruction: industry-leading all-round simulation
The immune system is a complex network involving the interaction of multiple immune cells. In order to more realistically simulate the human immune system, InnoModels' model realizes multi-cell reconstruction. This includes a variety of immune cells such as T-cells, B-cells, NK-cells, macrophages, DC-cells and so on. Each cell plays its unique role in the model, and together they form a complete immune system network.
Through multicellular reconstruction, the model from InnoModels Biotechnology is able to more comprehensively simulate the responses and changes of the human immune system. Researchers can use these models to study the interactions between different cells, investigate the mechanisms of disease onset and progression, and evaluate the effects of drugs on the immune system. This all-encompassing simulation capability makes InnoModels' models a leader in the industry.
III. Close to Human Concentration: Providing a Realistic Environment for Drug Testing
Drug testing is an important part of medical research, and its results are directly related to the safety and effectiveness of drugs. In order to more accurately assess the effects of drugs, a testing platform close to the real environment of the human body is needed. The humanized model of the immune system of InnoModels Biotechnology meets this need.
The reconstructed number of immune cells in the model can reach or approach the concentration of human immune cells, providing a more realistic environment for drug testing. This means that researchers can simulate the metabolism and action process of drugs in the human body in the model, and predict the effects of drugs on the immune system, so as to screen for safer and more effective drugs.
In summary, the humanized model of the immune system by InnoModels Biotechnology has brought new breakthroughs in medical research with its advantages of high stability, multi-cell reconstruction and close concentration to the human body. With the continuous improvement and application of this model, it is believed that future medical research will be more in-depth, precise and efficient.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd